There is significant heterogeneity in formulary placement and restrictions on new drug approvals in the Part D marketplace.
Danya Qato, PhD
Advertisement
Articles by Danya Qato, PhD
Advertisement
Latest Updated Articles
- Placement of Selected New FDA-Approved Drugs in Medicare Part D Formularies, 2009-2013
Published: June 6th 2018 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Cytokines Linked With Drug Resistance in Ovarian Cancer, but Underlying Mechanisms Remain Unclear
2
Mepolizumab Reduces Health Care Resource Utilization, Work Impairment in Severe Asthma
3
CHEST 2025 Highlights: Future of Respiratory Vaccines and the Impact of Federal Funding Cuts
4
FDA Expands Sotatercept Indication for PAH
5
